Publication:
Anti-double stranded DNA antibodies: Electrochemical isotyping in autoimmune and neurological diseases

dc.contributor.authorArévalo, Beatriz
dc.contributor.authorSerafín, Verónica
dc.contributor.authorGarranzo-Asensio, Maria
dc.contributor.authorMontero-Calle, Ana Maria
dc.contributor.authorBarderas Manchado, Rodrigo
dc.contributor.authorYáñez-Sedeño, Paloma
dc.contributor.authorCampuzano, Susana
dc.contributor.authorPingarrón, José M
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)
dc.contributor.funderMinisterio de Educación, Cultura y Deporte (España)
dc.date.accessioned2023-06-06T13:40:23Z
dc.date.available2023-06-06T13:40:23Z
dc.date.issued2023-05-29
dc.description.abstractThis work reports the first amperometric biosensor for the simultaneous determination of the single or total content of the most relevant human immunoglobulin isotypes (hIgs) of anti-dsDNA antibodies, dsDNA-hIgG, dsDNA-hIgM, dsDNA-hIgA and dsDNA-three hIgs, which are considered relevant biomarkers in prevalent autoimmune diseases such as systemic lupus erythematosus (SLE) as well as of interest in neurodegenerative diseases such as Alzheimer's disease (AD). The bioplatform involves the use of neutravidin-functionalized magnetic microparticles (NA-MBs) modified with a laboratory-prepared biotinylated human double-stranded DNA (b-dsDNA) for the efficient capture of specific autoantibodies that are enzymatically labeled with horseradish peroxidase (HRP) enzyme using specific secondary antibodies for each isotype or a mixture of secondary antibodies for the total content of the three isotypes. Transduction was performed by amperometry (-0.20 V vs. the Ag pseudo-reference electrode) using the H2O2/hydroquinone (HQ) system after trapping the resulting magnetic bioconjugates on each of the four working electrodes of a disposable quadruple transduction platform (SP4CEs). The bioplatform demonstrated attractive operational characteristics for clinical application and was employed to determine the individual or total hIgs classes in serum from healthy individuals and from patients diagnosed with SLE and AD. The target concentrations in AD patients are provided for the first time in this work. In addition, the results for SLE patients and control individuals agree with those obtained by applying ELISA tests as well as with the clinical ranges reported by other authors, using individual detection methodologies restricted to centralized settings or clinical laboratories.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe financial support of PID2019-103899RB-I00 and PID2021-122457OB-I00 (Spanish Ministerio de Ciencia e Innovación) Research Projects, PI17CIII/00045 and PI20CIII/00019 Grants from the AESISCIII Program co-founded by FEDER funds and the TRANSNANOAVANSENS-CM Program from the Comunidad de Madrid (Grant S2018/NMT-4349) are gratefully acknowledged. B.A. acknowledges predoctoral contracts from the Spanish Ministerio de Ciencia, Innovación y Universidades (PRE2019-087596). M.G-A. acknowledges the postdoctoral contract Margarita Salas for the requalification of the Spanish University System. A.M-C. was supported by a FPU predoctoral contract supported by the Spanish Ministerio de Educación, Cultura y Deporte.es_ES
dc.format.page341153es_ES
dc.format.volume1257es_ES
dc.identifier.citationAnal Chim Acta. 2023 May 29;1257:341153.es_ES
dc.identifier.doi10.1016/j.aca.2023.341153es_ES
dc.identifier.e-issn1873-4324es_ES
dc.identifier.journalAnalytica chimica actaes_ES
dc.identifier.pubmedID37062567es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16151
dc.language.isoenges_ES
dc.publisherElsevier
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-103899RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-122457OB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PRE2019-087596es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI17-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2017)/PI17CIII/00045es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI20-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2020)/PI20CIII/00019es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.aca.2023.341153es_ES
dc.repisalud.centroISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectElectrochemical immunoplatformes_ES
dc.subjectIsotypinges_ES
dc.subjectQuadruple detectiones_ES
dc.subjectSLEes_ES
dc.subjectSerumes_ES
dc.subjectdsDNA-Abses_ES
dc.subject.meshHydrogen Peroxidees_ES
dc.subject.meshLupus Erythematosus, Systemices_ES
dc.subject.meshHumanses_ES
dc.subject.meshAntibodies, Antinucleares_ES
dc.subject.meshImmunoglobulin Isotypeses_ES
dc.subject.meshAutoantibodieses_ES
dc.subject.meshDNAes_ES
dc.titleAnti-double stranded DNA antibodies: Electrochemical isotyping in autoimmune and neurological diseaseses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication840089f4-4c1e-4ac0-8214-93464312af82
relation.isAuthorOfPublication3e80abe1-6578-487f-8201-f4c5ed3a674c
relation.isAuthorOfPublicationdfb1f4f9-c8e8-4087-9db5-6477d4f154e4
relation.isAuthorOfPublication.latestForDiscovery840089f4-4c1e-4ac0-8214-93464312af82
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication1aef4c3b-1ee5-4534-83b4-3f3811c67280
relation.isFunderOfPublication41383d53-27b2-4b36-a8d4-ead2ae8fe63b
relation.isFunderOfPublication.latestForDiscovery289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Anti-doubleStrandedDNA_Antibodies_2023.pdf
Size:
4.29 MB
Format:
Adobe Portable Document Format
Description: